Early-Onset Colorectal (Bowel) Cancer
Clinical Practice Guidelines
Recommendation Strength
When assessing the quality of the evidence for any given topic, each recommendation is given a rating known as a Strength. This helps the reader understand if the benefits of the intervention are greater than the disadvantages. We have used the GRADE framework (Grading of Recommendations Assessment, Development and Evaluation) to determine the Strength of the recommendations.
The GRADE framework uses the following:
There is high or moderate certainty evidence that an intervention provides a net benefit.
There is high or moderate certainty evidence that it results in a net harm.
There is uncertainty about the net effect of an intervention compared with the alternative but is deemed to be possibly beneficial. This may be due to limited evidence, variability in values on outcomes, evidence suggesting similarly weighted benefits and harms.
There is uncertainty about the net effect of an intervention compared with the alternative but is deemed to be possibly harmful. This may be due to limited evidence, variability in values on outcomes, evidence suggesting similarly weighted benefits and harms.
Evidence is absent or of insufficient certainty; or there is an unclear balance between benefits and harms. A decision is made on a recommendation in answer to the clinical question based on the informed judgement of the Guidelines Leadership Group.
There is high certainty of an interventions net positive but no direct supporting evidence. It has clear actionability, necessity, justifiability, efficiency and explicit rationale but is not supported by a systematic search.
A gap in the evidence has been identified as a priority for future research.

